Xbiotech Inc stock is traded at $1.95, with a volume of 1,638. It is up 0.00% in the last 24 hours and down -14.85% over the past month. XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Previous Close:
$1.95
Open:
$1.96
24h Volume:
1,638
Relative Volume:
0.03
Market Cap:
$59.45M
Revenue:
$300.00K
Net Income/Loss:
-$40.16M
P/E Ratio:
-
EPS:
-$1.32
Net Cash Flow:
-$42.36M
1W Performance:
+4.28%
1M Performance:
-14.85%
6M Performance:
-22.00%
1Y Performance:
-29.60%
1-Day Range:
$1.95$1.96
1-Week Range:
$1.86$1.98
52-Week Range:
$1.80$3.44
Xbiotech Inc Stock (XBIT) Company Profile
Name
Xbiotech IncSector
HealthcareIndustry
BiotechnologyPhone
512-386-2900Address
5217 WINNEBAGO LANE, AUSTIN, TX, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS